• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Dave Loschinskey Joins Advanced Dermatology and Cosmetic Surgery as Executive Vice President of Operations

    7/19/21 10:05:00 AM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email

    Advanced Dermatology and Cosmetic Surgery (ADCS), one of the nation's leaders in high-quality dermatology, today announced the appointment of David Loschinskey as Executive Vice President of Operations.

    Mr. Loschinskey most recently founded 8th Day Labs to provide executive services to small and midsize companies with a wide range of services, including executive mentoring, operational planning and optimization, technology strategic planning, and mergers and acquisitions diligence services. 8th Day Labs is a sequel to 8th Day Software, which Mr. Loschinskey also founded and served as CEO in 2013. 8th Day Software satisfied a market need for reliable and cost-effective health care-related software that developed solutions for oncology treatment programs, patient engagement, pharmaceutical reporting and complex data integrations.

    Mr. Loschinskey also served as Chief Information Officer and Chief Operations Officer at Diplomat Pharmacy, Inc., once the largest independent provider of specialty pharmacy services in the United States. He managed the operations teams to ensure the highest quality of patient care and his responsibilities included overseeing technology, security, facilities and clinical/nursing.

    Diplomat was acquired by Optum Rx, a subsidiary of UnitedHealth Group (NYSE:UNH), in February 2020. Mr. Loschinskey was instrumental in executing the due diligence process and successful sale of the company.

    "I have known Dave for nearly 20 years, and he is a strong executive leader with proven success in optimizing operational performance and driving strategic growth," said Brian T. Griffin, Chief Executive Officer of Advanced Dermatology and Cosmetic Surgery. "Advanced Dermatology and Cosmetic Surgery is the premier leader of providing high-quality dermatological and aesthetic services, and with Dave's prior accomplishments, specifically related to mergers and acquisitions integrations and enhancing the overall patient and provider experience, I am confident in his ability to take ADCS to the next level."

    "We welcome Dave and look forward to his contributions to our growth and continued success," said Dr. Matt Leavitt, Executive Chairman and Founder of ADCS.

    "I'm excited to join Advanced Dermatology and Cosmetic Surgery," Loschinskey said. We have a rich clinical history and a passionate and talented team. I look forward to helping the company continue its innovative leadership and strong performance for our patients."

    ABOUT ADVANCED DERMATOLOGY AND COSMETIC SURGERY

    Advanced Dermatology and Cosmetic Surgery is the nation's largest dermatology practice. ADCS is committed to providing comprehensive and unparalleled dermatologic and aesthetic care in a welcoming and engaging environment, seeking to make each patient experience unique and adhering to superior patient safety and privacy standards. The company combines the best of the art of medicine with the latest advances in research and technology in formulating individualized treatment plans to achieve a unique, desired, and aesthetically pleasing result. To learn more about Advanced Dermatology or inquire about employment opportunities, visit www.advancedderm.com or call 1-866-400-DERM.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210719005194/en/

    Get the next $UNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    6/11/2025$312.00Outperform → Neutral
    Robert W. Baird
    5/21/2025$270.00Hold → Reduce
    HSBC Securities
    5/19/2025$308.00Buy → Hold
    TD Cowen
    5/14/2025Strong Buy → Mkt Perform
    Raymond James
    5/14/2025$350.00Buy → Neutral
    BofA Securities
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    4/21/2025Buy → Hold
    Argus
    1/10/2025$595.00Hold → Buy
    HSBC Securities
    More analyst ratings